November 17, 2025
1 min read

FDA Limits Duchenne Gene Therapy, Elevidys, After Two Teens Die of Liver Failure

MONDAY, Nov. 17, 2025 The U.S. Food and Drug Administration (FDA) is tightening restrictions on a gene therapy used to treat Duchenne muscular dystrophy after t

Leave a Reply

Your email address will not be published.

Previous Story

A cervical cancer prevention milestone

Next Story

Washington Reports First Human Case of Rare Bird Flu Strain

Previous Story

A cervical cancer prevention milestone

Next Story

Washington Reports First Human Case of Rare Bird Flu Strain

Latest from Blog

ROFI Drives New Approach to Crop Nutrition

With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader

STAT+: A new attack on AMA’s billing codes

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Brain
Go toTop